Skip to Main Content
research
nutrition
Cancer
Reporting from the frontiers of health and medicine
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
The Readout
STAT+

What makes a drug a blockbuster — or a cautionary tale?

  • Meghana Keshavan

By Meghana Keshavan Feb. 2, 2024

Reprints
Vertex
Craig F. Walker/The Boston Globe

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hey there. Today, we talk about how biomanufacturing is getting a huge boost in North Carolina, study a new potential root for autoimmune disease in women, and more.

advertisement

The need-to-know this morning

  • Bristol Myers Squibb reported fourth quarter and 2023 earnings. For 2024, the company said it expects total sales to increase “low single digits” from $45 billion in 2023. Current Street consensus has Bristol growing sales 2%.
  • More earnings: Regeneron Pharmaceuticals and Abbvie.

What makes a blockbuster?

Can biotech learn from Aduhelm? And how do you replace a singular regulator? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.

Drug development was once a marathon. New tools and…
Drug development was once a marathon. New tools and timelines are turning it into a sprint
Medical devices makers are trying to take a page…
Medical devices makers are trying to take a page from Uber’s playbook
A study says intermittent fasting is making people drop…
A study says intermittent fasting is making people drop dead. Oh, come on
FDA authorizes new drug to protect immune compromised from…
FDA authorizes new drug to protect immune compromised from Covid-19
Abortion law emergency-exemption guidance proposed by Texas Medical Board
Abortion law emergency-exemption guidance proposed by Texas Medical Board
How biotech investors spot opportunity when stocks are down…
How biotech investors spot opportunity when stocks are down — and up

Recommended Stories